Dividend Growth Investing

dividends stocks investing

  • Home
  • About
  • Bookstore
  • Returns Calculator
  • Portfolio
  • Getting Started

Recent Buy: CVS

July 21, 2020 by Mike M Leave a Comment

The disconnect between stocks and the economy continues!  Share prices are still trading close to all-time record highs, at least on the surface.  Tech companies and Covid beneficiaries are surging.  Meanwhile travel, leisure, energy, and many more businesses continue to struggle.  In my personal portfolio, Apple, Fastenal, … [Read more...]

Filed Under: Portfolio Update Tagged With: amazon, cvs, dividends, drugs, earnings, healthcare, stocks

Recent Buy: ABBV

September 14, 2019 by Mike M 1 Comment

For the month of September, I went after a deep discount but took on some risk.  I purchased 16 shares of Abbvie (ABBV) at a price of around $65/share.  Abbvie is a global researcher, manufacturer, and marketer of pharmaceuticals.  Products developed treat conditions related to autoimmune disorders, gastroenterology, neurology, oncology, … [Read more...]

Filed Under: Portfolio Update Tagged With: abbvie, allergan, dividends, drugs, humira, risk, stocks

Recent Buy: MMM & GSK

November 15, 2018 by Mike M Leave a Comment

Now that the midterms are over, investors have a bit more clarity over what’s coming. The United States now faces a divided government. For investors this means nothing, literally nothing. Because Democrats control the House and Republicans hold the Senate, there’s total gridlock. When nothing gets done businesses can plan strategically for 2 … [Read more...]

Filed Under: About Tagged With: dividends, drugs, healthcare, revenue, stocks, vaccines

Recent Buy: Amgen

September 30, 2017 by Mike M 2 Comments

The market just keeps going higher! Tax reform, Fed ambiguity, and fewer headlines on North Korea continue to drive equities forward. I like the gains but at the same time it’s almost impossible to find a cheap stock. I was going to buy Sonoco but the share price is now over $50. I can’t quite pay $50/share. Even $48 was a stretch given the … [Read more...]

Filed Under: Portfolio Update Tagged With: amgen, amgn, buy, dividends, drugs, earnings, stocks

Dividend Investors:

Subscribe here for my latest content!

Connect with me on social media!

Featured Book:

Click the above image to see on Amazon.

Recent Posts

  • January 2021 (1)
  • December 2020 (1)
  • November 2020 (1)
  • October 2020 (1)
  • September 2020 (1)
  • July 2020 (1)
  • June 2020 (2)
  • May 2020 (1)
  • April 2020 (2)
  • March 2020 (1)
  • February 2020 (1)
  • January 2020 (1)
  • December 2019 (2)
  • November 2019 (2)
  • October 2019 (3)
  • September 2019 (5)
  • August 2019 (2)
  • July 2019 (1)
  • June 2019 (3)
  • May 2019 (3)
  • April 2019 (2)
  • March 2019 (1)
  • February 2019 (1)
  • January 2019 (2)
  • December 2018 (2)
  • November 2018 (2)
  • October 2018 (1)
  • September 2018 (2)
  • August 2018 (2)
  • July 2018 (2)
  • June 2018 (3)
  • May 2018 (3)
  • April 2018 (3)
  • March 2018 (3)
  • February 2018 (2)
  • January 2018 (2)
  • December 2017 (3)
  • November 2017 (2)
  • October 2017 (2)
  • September 2017 (3)
  • August 2017 (3)
  • July 2017 (4)
  • June 2017 (3)
  • May 2017 (3)
  • April 2017 (3)
  • March 2017 (3)
  • February 2017 (2)
  • January 2017 (3)
  • December 2016 (3)
  • November 2016 (2)
  • October 2016 (3)
  • September 2016 (2)
  • August 2016 (4)
  • July 2016 (4)
  • June 2016 (3)
  • May 2016 (3)
  • April 2016 (4)
  • March 2016 (5)
  • February 2016 (4)

Calendar

March 2021
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
« Jan    

Disclaimer

I am not a licensed investment advisor or tax professional. I am not liable for any losses incurred by any parties. This blog should be viewed for entertainment and/or educational purposes only. Any transactions published are not recommendations to buy or sell any securities. Please consult with an investment professional before making investment decisions.

Privacy Policy

This blog does not collect any personal information except that which is freely shared publicly. I will never sell personal information of any visitors for any purpose.

Disclosure

This blog may have third-party ads served up at any time. I do not make any claims to accuracy of these ads, and these ads do not necessarily represent this blog's views or opinions. I will note any Affiliate partner links I recommend and receive compensation for. We may also publish articles that are paid for by third-party advertisers, and these will be categorized as sponsored posts.

Copyright © 2021 · Author Pro Theme on Genesis Framework · WordPress · Log in

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT